Supha Pharmachem Limited (BOM:539561)

Market Cap	346.75M
Revenue (ttm)	5.27B
Net Income (ttm)	122.54M
Shares Out	403.20M
EPS (ttm)	0.19
PE Ratio	4.60
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,580,676
Average Volume	9,872,193
Open	0.8400
Previous Close	0.8500
Day's Range	0.8400 - 0.8600
52-Week Range	0.6900 - 5.2500
Beta	1.04
RSI	45.62
Earnings Date	Feb 10, 2026

About Supha Pharmachem

Supha Pharmachem Limited, a pharmaceutical company, trades and sells active pharmaceutical ingredients (API) and intermediates in India and internationally. The company offers API intermediates and other products for the use in iso propyl alcohol, cyclohexane di iso propyl amine, ethyl acetate, hydrazine hydrate, iso propyl alcohol, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride and carbonate, amino isophthalic acid, tellurium(iv) oxide, grignard reagent, iodine, selenium meta...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1988
• Employees: 7
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539561

Financial Performance

In 2024, Supha Pharmachem's revenue was 4.05 billion, a decrease of -89.97% compared to the previous year's 40.42 billion. Earnings were 21.29 million, a decrease of -93.49%.